Active Ingredient History
Tetanus vaccine, also known as tetanus toxoid (TT), is a toxoid vaccine used to prevent tetanus. During childhood, five doses are recommended, with a sixth given during adolescence. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Diphtheria-Tetanus Vaccine (approved 1955)
Bacterial Infections (Phase 3)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Colonic Neoplasms (Phase 2)
Diarrhea (Phase 3)
Diffuse Intrinsic Pontine Glioma (Phase 2)
Diphtheria (Phase 4)
Diphtheria-Tetanus-Pertussis Vaccine (Phase 3)
Glioblastoma (Phase 1)
Glioma (Phase 2)
Healthy Volunteers (Phase 3)
Hepatitis C (Phase 1)
HIV (Phase 4)
HIV Infections (Phase 1)
Infections (Phase 2)
Medulloblastoma (Phase 2)
Melanoma (Phase 1)
Multiple Sclerosis (Phase 2)
Pertussis Vaccine (Phase 3)
Pneumococcal Infections (Phase 1)
Substance-Related Disorders (Early Phase 1)
Tetanus (Phase 4)
Urinary Bladder Neoplasms (Phase 2)
Whooping Cough (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue